Bell, I M <br/><br/>
Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines.  [electronic resource] 

 -  Journal of medicinal chemistry  Jun 1998 
 - 2146-63 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0022-2623 
<br/><br/><label>Standard No.: </label>10.1021/jm9800797  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Biological Availability<br/>Cell Line<br/>Chromatography, High Pressure Liquid<br/>Dogs<br/>Female<br/>Humans<br/>Kidney--cytology<br/>Liver--metabolism<br/>Male<br/>Mass Spectrometry<br/>Oxazines--chemical synthesis<br/>Pregnancy<br/>Pyridines--chemical synthesis<br/>Rats<br/>Receptors, Oxytocin--antagonists & inhibitors<br/>Recombinant Proteins--antagonists & inhibitors<br/>Spectrophotometry, Ultraviolet<br/>Uterine Contraction--drug effects<br/>Uterus--drug effects